A detailed history of N Verses Capital, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, N Verses Capital, LLC holds 100 shares of UTHR stock, worth $40,257. This represents 0.02% of its overall portfolio holdings.

Number of Shares
100
Previous 900 88.89%
Holding current value
$40,257
Previous $287 Million 87.5%
% of portfolio
0.02%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$311.04 - $363.55 $248,832 - $290,840
-800 Reduced 88.89%
100 $35.8 Million
Q2 2024

Jul 31, 2024

BUY
$228.26 - $319.04 $205,434 - $287,136
900 New
900 $287 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $18.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.